As per SNS Insider Research, The DNA Manufacturing Market growth is driven by plasmid DNA demand, biopharma innovation, and advancements in DNA-based vaccine production.Austin, Nov. 07, 2025 (GLOBE ...
Biopharmaceuticals: Redefining the Future of Modern MedicineThe Global Bio Pharmaceuticals Market is valued at USD 421.58 ...
Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.
Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.
SITC abstracts highlight updated immunogenicity results from the Phase 2 AMPLIFY-7P trial of ELI-002 7P and preclinical data on the use of ...
New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, with initial ...
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...
FDA Policy Changes Could Bring Some Biosimilars To Market Faster. Legal News and Analysis - USA - Intellectual Property - Conventus Law ...
Genetic engineers can design and assemble sophisticated gene circuits to program cells with new functions, but important ...
Key opportunities in the U.S. regenerative medicine market include the rising adoption of stem cell technology and a strong ...
The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a Convertible Bonds financing facility with Nice&Green CNS(Vafidemstat) Received feedback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback